AstraZeneca, Samsung Biologics shut down joint venture – report

Maggio 24, 2022

Samsung Biologics Co. has shut down its joint venture with pharmaceutical company AstraZeneca Plc, Yonhap News Agency reported citing a company official.

The two have decided to completely abandon th…

← Europe lower premarket with no Ukraine peace in sight
Samsung to invest $360B in chips, bioscience, AI →

Potrebbe anche interessarti

Putin, Biden to speak on February 12

How Germany let a domestic squabble hobble a key part of Europe’s green ambitions

Ukraine warns of ‘second wave’ of drone attacks